EW Healthcare Partners LP, 10% Owner at EyePoint Pharmaceuticals (NASDAQ:EYPT), reported a large insider sell on August 30, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that LP sold 223,936 shares of EyePoint Pharmaceuticals. The total transaction amounted to $2,487,482.
EyePoint Pharmaceuticals shares are trading down 3.8% at $10.64 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily ...